![]() |
인쇄하기
취소
|
The pharmaceutical industry has paid attention that the antismoking treatment ‘Champix’, which has become a failure due to the unfavorable factor of suicidal impulse, will hit its 2nd golden age.
Since the coming February, the government will support patients who register for antismoking programs with 12-week counseling, nicotine patches and antismoking supplements that can be supported from 3...